Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study
- 1 December 2017
- journal article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 17 (12), 1285-1292
- https://doi.org/10.1016/s1473-3099(17)30488-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Point-of-Care C-Reactive Protein Testing to Facilitate Implementation of Isoniazid Preventive Therapy for People Living With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
- Undiagnosed Tuberculosis Among HIV Clinic AttendeesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective StudyPLoS Medicine, 2011
- Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational StudiesPLoS Medicine, 2011
- Performance of Serum C-Reactive Protein as a Screening Test for Smear-Negative Tuberculosis in an Ambulatory High HIV Prevalence PopulationPLOS ONE, 2011
- Prognostic value of C-reactive protein in HIV-infected patients with Pneumocystis jirovecii pneumoniaInternational Journal of STD & AIDS, 2010
- Role of C-Reactive Protein and Procalcitonin in Differentiation of Tuberculosis from Bacterial Community Acquired PneumoniaThe Korean Journal of Internal Medicine, 2009
- Inflammation markers in point-of-care testing (POCT)Analytical and Bioanalytical Chemistry, 2008
- Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumoniaEuropean Respiratory Journal, 2005
- Solid phase radioimmunoassays for human C-reactive proteinClinica Chimica Acta; International Journal of Clinical Chemistry, 1981